Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: Role of altered catecholamines and BDNF

Experimental Neurology

Volumn 254, Issue , 2014, Pages 145-152

  Yochum, Carrie ^a,b   Doherty Lyon, Shannon ^c   Hoffman, Carol ^c   Hossain, Muhammad M ^a,b   Zelikoff, Judith T ^c   Richardson, Jason R ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADHD; Aggression; BDNF; Dopamine; Hyperactivity; Maternal smoking; Nicotine

Indexed keywords

ADHD; AGGRESSION; BDNF; DOPAMINE; HYPERACTIVITY; MATERNAL SMOKING; NICOTINE;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINES; DISEASE MODELS, ANIMAL; FEMALE; HYPERKINESIS; LITTER SIZE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX CHARACTERISTICS; TOBACCO SMOKE POLLUTION;

EID: 84893904292     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.01.016     Document Type: Article

References (58)

1. Amos-Kroohs R.M., Williams M.T., Braun A.A., Graham D.L., Webb C.L., Birtles T.S., Greene R.M., Vorhees C.V., Pisano M.M. Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke. Neurotoxicol. Teratol. 2013, 35:34-45. 10.1016/j.ntt.2013.01.001.
2. Ball S.W., Gilman S.E., Mick E., Fitzmaurice G., Ganz M.L., Seidman L.J., Buka S.L. Revisiting the association between maternal smoking during pregnancy and ADHD. J. Psychiatr. Res. 2010, 44(15):1058-1062. 10.1016/j.jpsychires.2010.03.009.
3. Banerjee T.D., Middleton F., Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007, 96(9):1269-1274. 10.1111/j.1651-2227.2007.00430.x.
4. Bradner J.M., Suragh T.A., Wilson W.W., Lazo C.R., Stout K.A., Kim H.M., Wang M.Z., Walker D.I., Pennell K.D., Richardson J.R., Miller G.W., Caudle W.M. Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity. Exp. Neurol. 2013, 241:138-147. 10.1016/j.expneurol.2012.12.013.
5. Braun J.M., Kahn R.S., Froehlich T., Auinger P., Lanphear B.P. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ. Health Perspect. 2006, 114(12):1904-1909.
6. Bruin J.E., Gerstein H.C., Holloway A.C. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol. Sci. 2010, 116(2):364-374. 10.1093/toxsci/kfq103.
7. Cherek D.R. Effects of cigarette smoking on human aggressive behavior. Prog. Clin. Biol. Res. 1984, 169:333-344.
8. Cornelius M.D., Goldschmidt L., Day N.L. Prenatal cigarette smoking: long-term effects on young adult behavior problems and smoking behavior. Neurotoxicol. Teratol. 2012, 34(6):554-559. 10.1016/j.ntt.2012.09.003.
9. Dluzen D.E., Anderson L.I., McDermott J.L., Kucera J., Walro J.M. Striatal dopamine output is compromised within +/- BDNF mice. Synapse 2002, 43(2):112-117. 10.1002/syn.10027.
10. Driscoll P., Baettig K. Selective inhibition by nicotine of shock-induced fighting in the rat. Pharmacol. Biochem. Behav. 1981, 14(2):175-179.
11. Fortin M.C., Aleksunes L.M., Richardson J.R. Alteration of the expression of pesticide-metabolizing enzymes in pregnant mice: potential role in the increased vulnerability of the developing brain. Drug Metab. Dispos. 2013, 41(2):326-331. 10.1124/dmd.112.049395.
12. Froehlich T.E., Lanphear B.P., Auinger P., Hornung R., Epstein J.N., Braun J., Kahn R.S. Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 2009, 124(6):e1054-e1063. 10.1542/peds.2009-0738.
13. Fung Y.K. Postnatal behavioural effects of maternal nicotine exposure in rats. J. Pharm. Pharmacol. 1988, 40(12):870-872.
14. Fung Y.K., Lau Y.S. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol. Biochem. Behav. 1989, 33(1):1-6.
15. Gaworski C.L., Carmines E.L., Faqi A.S., Rajendran N. In utero and lactation exposure of rats to 1R4F reference cigarette mainstream smoke: effect on prenatal and postnatal development. Toxicol. Sci. 2004, 79(1):157-169. 10.1093/toxsci/kfh083.
16. Harrod S.B., Lacy R.T., Zhu J., Hughes B.A., Perna M.K., Brown R.W. Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse 2011, 65(12):1382-1392. 10.1002/syn.20975.
17. Indredavik M.S., Brubakk A.M., Romundstad P., Vik T. Prenatal smoking exposure and psychiatric symptoms in adolescence. Acta Paediatr. 2007, 96(3):377-382. 10.1111/j.1651-2227.2006.00148.x.
18. Johnson S.K., Carlson K.M., Lee J., Burr L.E., Wagner G.C. Effects of nicotine on target biting and resident-intruder attack. Life Sci. 2003, 73(3):311-317.
19. Keyes K.M., Keyes M.A., March D., Susser E. Levels of risk: maternal-, middle childhood-, and neighborhood-level predictors of adolescent disinhibitory behaviors from a longitudinal birth cohort in the United States. Ment. Health Subst. Use Dual Diagn. 2011, 4(1):22-37.
20. Knopik V.S. Maternal smoking during pregnancy and child outcomes: real or spurious effect?. Dev. Neuropsychol. 2009, 34(1):1-36. 10.1080/87565640802564366.
21. Langley K., Rice F., van den Bree M.B., Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr. 2005, 57(6):359-371.
22. Langley K., Heron J., Smith G.D., Thapar A. Maternal and paternal smoking during pregnancy and risk of ADHD symptoms in offspring: testing for intrauterine effects. Am. J. Epidemiol. 2012, 176(3):261-268. 10.1093/aje/kwr510.
23. Leech S.L., Richardson G.A., Goldschmidt L., Day N.L. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol. Teratol. 1999, 21(2):109-118.
24. Lindblad F., Hjern A. ADHD after fetal exposure to maternal smoking. Nicotine Tob. Res. 2010, 12(4):408-415. 10.1093/ntr/ntq017.
25. Linnet K.M., Dalsgaard S., Obel C., Wisborg K., Henriksen T.B., Rodriguez A., Kotimaa A., Moilanen I., Thomsen P.H., Olsen J., Jarvelin M.R. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am. J. Psychiatr. 2003, 160(6):1028-1040.
26. Linnet K.M., Wisborg K., Obel C., Secher N.J., Thomsen P.H., Agerbo E., Henriksen T.B. Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics 2005, 116(2):462-467. 10.1542/peds.2004-2054.
27. Lu B., Figurov A. Role of neurotrophins in synapse development and plasticity. Rev. Neurosci. 1997, 8(1):1-12.
28. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(26):15239-15244.
29. Milberger S., Biederman J., Faraone S.V., Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J. Clin. Child Psychol. 1998, 27(3):352-358. 10.1207/s15374424jccp2703_11.
30. Monteggia L.M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L.F., Nestler E.J. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 2007, 61(2):187-197. 10.1016/j.biopsych.2006.03.021.
31. Mosienko V., Bert B., Beis D., Matthes S., Fink H., Bader M., Alenina N. Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl. Psychiatry 2012, 2:e122. 10.1038/tp.2012.44.
32. Muneoka K., Ogawa T., Kamei K., Muraoka S., Tomiyoshi R., Mimura Y., Kato H., Suzuki M.R., Takigawa M. Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res. Dev. Brain Res. 1997, 102(1):117-126.
33. Navarro H.A., Seidler F.J., Whitmore W.L., Slotkin T.A. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J. Pharmacol. Exp. Ther. 1988, 244(3):940-944.
34. Ng S.P., Steinetz B.G., Lasano S.G., Zelikoff J.T. Hormonal changes accompanying cigarette smoke-induced preterm births in a mouse model. Exp. Biol. Med. (Maywood) 2006, 231(8):1403-1409.
35. Obel C., Linnet K.M., Henriksen T.B., Rodriguez A., Jarvelin M.R., Kotimaa A., Moilanen I., Ebeling H., Bilenberg N., Taanila A., Ye G., Olsen J. Smoking during pregnancy and hyperactivity-inattention in the offspring-comparing results from three Nordic cohorts. Int. J. Epidemiol. 2009, 38(3):698-705. 10.1093/ije/dym290.
36. Obel C., Olsen J., Henriksen T.B., Rodriguez A., Jarvelin M.R., Moilanen I., Parner E., Linnet K.M., Taanila A., Ebeling H., Heiervang E., Gissler M. Is maternal smoking during pregnancy a risk factor for hyperkinetic disorder?-Findings from a sibling design. Int. J. Epidemiol. 2011, 40(2):338-345. 10.1093/ije/dyq185.
37. Oliff H.S., Gallardo K.A. The effect of nicotine on developing brain catecholamine systems. Front. Biosci. 1999, 4:D883-D897.
38. Pauly J.R., Sparks J.A., Hauser K.F., Pauly T.H. In utero nicotine exposure causes persistent, gender-dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int. J. Dev. Neurosci. 2004, 22(5-6):329-337. 10.1016/j.ijdevneu.2004.05.009.
39. Peacock J.L., Cook D.G., Carey I.M., Jarvis M.J., Bryant A.E., Anderson H.R., Bland J.M. Maternal cotinine level during pregnancy and birthweight for gestational age. Int. J. Epidemiol. 1998, 27(4):647-656.
40. Richardson S.A., Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways. Pharmacol. Biochem. Behav. 1994, 47(2):331-337.
41. Richardson J.R., Caudle W.M., Wang M.Z., Dean E.D., Pennell K.D., Miller G.W. Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in a gender-specific manner. Neurotoxicology 2008, 29(5):855-863. 10.1016/j.neuro.2008.05.007.
42. Schneider T., Bizarro L., Asherson P.J., Stolerman I.P. Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology 2012, 223(4):401-415. 10.1007/s00213-012-2728-7.
43. Scholtens J., Roozen M., Mirmiran M., van de Poll N.E. Role of noradrenaline in behavioral changes after defeat in male and female rats. Behav. Brain Res. 1990, 36(3):199-202.
44. Schuh R.A., Richardson J.R., Gupta R.K., Flaws J.A., Fiskum G. Effects of the organochlorine pesticide methoxychlor on dopamine metabolites and transporters in the mouse brain. Neurotoxicology 2009, 30(2):274-280.
45. Sheleg M., Yochum C.L., Wagner G.C., Zhou R., Richardson J.R. Ephrin-A5 deficiency alters sensorimotor and monoaminergic development. Behav. Brain Res. 2013, 236(1):139-147. 10.1016/j.bbr.2012.08.032.
46. Silverman A.P. Behaviour of rats given a "smoking dose" of nicotine. Anim. Behav. 1971, 19(1):67-74.
47. Slikker W., Xu Z.A., Levin E.D., Slotkin T.A. Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction-developmental neurotoxicity of nicotine. Crit. Rev. Toxicol. 2005, 35(8-9):703-711.
48. Slotkin T.A. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol. Teratol. 2008, 30(1):1-19.
49. Son J.H., Winzer-Serhan U.H. Chronic neonatal nicotine exposure increases mRNA expression of neurotrophic factors in the postnatal rat hippocampus. Brain Res. 2009, 1278:1-14. 10.1016/j.brainres.2009.04.046.
50. Swan G.E., Lessov-Schlaggar C.N. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol. Rev. 2007, 17(3):259-273. 10.1007/s11065-007-9035-9.
51. Thapar A., Fowler T., Rice F., Scourfield J., van den Bree M., Thomas H., Harold G., Hay D. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psychiatr. 2003, 160(11):1985-1989.
52. Thapar A., Rice F., Hay D., Boivin J., Langley K., van den Bree M., Rutter M., Harold G. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol. Psychiatry 2009, 66(8):722-727. 10.1016/j.biopsych.2009.05.032.
53. Vergnes M., Depaulis A., Boehrer A. Parachlorophenylalanine-induced serotonin depletion increases offensive but not defensive aggression in male rats. Physiol. Behav. 1986, 36(4):653-658.
54. Weissman M.M., Warner V., Wickramaratne P.J., Kandel D.B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J. Am. Acad. Child Adolesc. Psychiatry 1999, 38(7):892-899. 10.1097/00004583-199907000-00020.
55. Wigle D.T., Arbuckle T.E., Turner M.C., Berube A., Yang Q., Liu S., Krewski D. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J. Toxicol. Environ. Health B Crit. Rev. 2008, 11(5-6):373-517. 10.1080/10937400801921320.
56. Yochum C.L., Dowling P., Reuhl K.R., Wagner G.C., Ming X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res. 2008, 1203:126-132. 10.1016/j.brainres.2008.01.055.
57. Zagrodzka J., Wieczorek M., Romaniuk A. Social interactions in rats: behavioral and neurochemical alterations in DSP-4-treated rats. Pharmacol. Biochem. Behav. 1994, 49(3):541-548.
58. Zhu J., Zhang X., Xu Y., Spencer T.J., Biederman J., Bhide P.G. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment. J. Neurosci. 2012, 32(27):9410-9418. 10.1523/JNEUROSCI.1041-12.2012.